echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Long-eye exploration meeting, Sichuan Pharmaceutical Logistics Chamber of Commerce President Huang Ding: the future of private pharmaceutical commercial enterprises

    Long-eye exploration meeting, Sichuan Pharmaceutical Logistics Chamber of Commerce President Huang Ding: the future of private pharmaceutical commercial enterprises

    • Last Update: 2020-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Huang Ding, president of Sichuan Pharmaceutical Logistics Chamber of Commerce and chairman of Sichuan Herbal Medicine Co., Ltd., won the "2019 Top Ten People of the Year" award at the launch event of the 2nd National Summit Forum of Private Pharmaceutical Business Entrepreneurs and the 2019 National List of 100 Outstanding Private Pharmaceutical Commercial Circulation Enterprises.
    in order to better explore the future development of China's pharmaceutical business enterprises, especially private pharmaceutical business, Sina Pharmaceutical News Special Dialogue Chairman Huang.
    dialogue guest: Huang Ding zhong Q: Hello, Huang total.
    you today won the "2019 Private Pharmaceutical Business Top Ten Person of the Year"! May I ask you what do you think of the environment and living conditions that private pharmaceutical commercial enterprises are facing under the background of the deepening of China's medical reform? Huang: Now the overall orientation of the country's new medical reform policy is to "enhance the concentration of the industry, optimize the allocation of resources, improve the professional degree of operation, reduce the cost of circulation", whether for state-owned, private, mixed reform and other different ownership of the nature of pharmaceutical commercial enterprises, its impact is undoubtedly rapid, profound and far-reaching.
    , although there are many private pharmaceutical commercial enterprises in China, the overall operating strength, market share and industry influence still need to be improved.
    addition to Kyusju Tong, One Heart Hall and other listed enterprises, private pharmaceutical commercial enterprises or regional enterprises in the majority, characteristic enterprises in the majority, small and medium-sized enterprises in the majority.
    but also these "strength non-mainstream" private pharmaceutical commercial enterprises, in primary health care, retail terminals, rural distribution and other circulation end links to assume the main distribution functions of the market, or operating functions.
    , I think the private pharmaceutical commercial enterprises are currently in the accumulation of advantages, differences in survival, hard development, adversity to find a breakthrough."
    Q: So what trend do you think private pharmaceutical commercial enterprises will tend to trend towards in the future? Huang: In my opinion, the future of private pharmaceutical commercial enterprises "active change, deep integration, platform development" is the general trend.
    "active change" is to make trade-offs on their own survival.
    In Sichuan province, for example, the number of private pharmaceutical businesses has fallen significantly in the last two or three years, or has fallen to hundreds, and they may be forced to close due to mergers and acquisitions, changes, or inability to operate.
    "Deep integration" is the fundamental optimization of the enterprise's equity structure, or mixed with the state-owned enterprises, or with the listed enterprises, or between the private enterprises and private enterprises, cross-shareholding, etc., in order to achieve the absolute leading role of capital in the allocation of resources.
    "platform development" is to actively participate in social industry organizations (such as associations, alliances, etc.), actively learn the industry's emerging business philosophy and technology, group development, complementary development, the formation of platform advantages, to achieve platform effect.
    simple, that is, "small businesses" need to be integrated into the "big platform", "regional platform" needs to be integrated into the "national platform", "local small concept" needs to be connected to the "industry vision"! Q: I think you are also the chairman of Sichuan Herbal Medicine Company, can you help us introduce how our enterprise in the current policy and market environment innovation breakthrough? Huang: The establishment of Sichuan herbal medicine industry is due to the timely "standard governance" of the industry trend, the cohesion of wholesale transfer, retail chain, hospital pure sales and other multi-industry pharmaceutical business colleagues, partnership to open a standardized corporate operation; The trend, to absorb parts of the province city and county pharmaceutical commercial companies, retail chain companies set up a "group" intensive management, now and in the future, herbal medicine industry is to comply with the "active change, deep integration, platform development" industry trends, positive innovation, the courage to innovate, not only to live, but also to live better.
    can be said that the history and reality of herbal medicine industry shows that: "following the industry trend" is the fundamental breakthrough of innovation! Q: Finally, I would like to ask you to talk about, Xindu now to focus on the development of international medical and trade city, what do you think of the strategic planning of Xindu? Huang: Now every administrative district in Chengdu is fully exploiting its own characteristic advantages and carrying out the precise positioning of development strategy.
    For the pharmaceutical and medical trade industry, many districts attach great importance to, have made enough efforts to promote industrial development, but each has its own characteristics and emphasis, such as just said to Chengdu Tianfu Life Science and Technology Park, Wenjiang Chengdu Medical City, as well as Pengzhou Tianfu Chinese Medicine City.
    Xindu is now focusing on the development of Tianfu Medical and Trade City, but also based on its own basic advantages in the medical and trade industry, such as the number of medical and trade enterprises in the region, large-scale, convenient transportation, so as to achieve the misplaced competition with other districts, complementary promotion.
    I wish the new city accurate positioning, full promotion of the "Tianfu Medical and Trade City" strategy smoothly implemented, with remarkable results!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.